ChemAxon has appointed Alex Drijver as CEO. The arrival signals the company's increased focus on business development and market position. Ferenc Csizmadia, founder and former CEO, moves to chairman and head of research and development.
The new R&D position formalises the bridge between the customer base and the company’s development strategy and in particular the next generation of products under launch.
Drijver joins ChemAxon with more than 20 years international commercial experience, most recently as CEO and CFO of ThalesNano, a Budapest based manufacturer of novel microfluidic based instruments for chemical synthesis, and CFO of ComGenex, a chemistry services provider now part of Albany Molecular.